HomeQDEL • NASDAQ
Quidelortho Corp
$45.12
Makalipas ang Oras ng Trabaho:
$45.12
(0.00%)0.00
Sarado: Ene 27, 4:20:00 PM GMT-5 · USD · NASDAQ · Disclaimer
StockSegurong nakalista sa USMay headquarter sa US
Nakaraang pagsara
$44.24
Sakop ng araw
$43.83 - $46.24
Sakop ng taon
$29.74 - $71.57
Market cap
3.03B USD
Average na Volume
943.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(USD)Set 2024Y/Y na pagbabago
Kita
727.10M-2.27%
Gastos sa pagpapatakbo
300.50M-4.42%
Net na kita
-19.90M-56.69%
Net profit margin
-2.74-60.23%
Kita sa bawat share
0.85-5.56%
EBITDA
164.90M-1.90%
Aktuwal na % ng binabayarang buwis
30.90%—
Kabuuang asset
Kabuuang sagutin
(USD)Set 2024Y/Y na pagbabago
Cash at mga panandaliang investment
146.00M-26.30%
Kabuuang asset
6.80B-20.35%
Kabuuang sagutin
3.61B1.18%
Kabuuang equity
3.19B—
Natitirang share
67.26M—
Presyo para makapag-book
0.93—
Return on assets
1.92%—
Return on capital
2.17%—
Net change in cash
(USD)Set 2024Y/Y na pagbabago
Net na kita
-19.90M-56.69%
Cash mula sa mga operasyon
117.90M184.10%
Cash mula sa pag-invest
-56.50M-165.26%
Cash mula sa financing
-26.30M46.00%
Net change in cash
36.50M222.90%
Malayang cash flow
123.24M41.51%
Tungkol
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
Itinatag
1979
Mga Empleyado
7,100
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu